BridgeBio Oncology Therapeutics, Inc. - BBOT

Sector: Healthcare · Industry: Pharmaceutical Preparations

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q1 2026 · Q4 2025

Value (USD)

Total reported value ($000)

$523.7M

QoQ value delta ($000)

-$232.4M (-30.73%)

Implied price effect (QoQ)

-30.64%

Total shares

58,231,283

QoQ shares delta

-76,477 (-0.13%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q1 2026 data: 67 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
Cormorant Asset Management, LP	160,013	17,878,594	8.04%
DEERFIELD MANAGEMENT COMPANY, L.P.	43,724	4,885,446	0.52%
Omega Fund Management, LLC	29,442	3,289,661	18.05%
EcoR1 Capital, LLC	25,266	2,823,126	1.07%
Alphabet Inc.	25,266	2,823,126	0.63%
WELLINGTON MANAGEMENT GROUP LLP	25,224	2,818,348	0.0%
Enavate Sciences GP, LLC	23,511	2,626,946	6.69%
CITADEL ADVISORS LLC	22,632	2,528,762	0.0%
Novo Holdings A/S	19,564	2,185,923	1.59%
BlackRock, Inc.	18,690	2,088,297	0.0%
Laurion Capital Management LP	17,207	1,922,656	0.75%
ARMISTICE CAPITAL, LLC	11,885	1,328,000	0.21%
VANGUARD GROUP INC	9,904	791,095	0.0%
Aisling Capital Management LP	9,111	1,018,018	1.91%
Paradigm Biocapital Advisors LP	7,770	868,213	0.16%
Octagon Capital Advisors LP	6,435	719,000	0.71%
ROYCE & ASSOCIATES LP	5,696	636,522	0.06%
GEODE CAPITAL MANAGEMENT, LLC	5,186	579,234	0.0%
VANGUARD CAPITAL MANAGEMENT LLC	4,819	538,441	0.0%
EVENTIDE ASSET MANAGEMENT, LLC	4,697	541,181	0.08%
PRICE T ROWE ASSOCIATES INC /MD/	3,920	437,889	0.0%
ADAGE CAPITAL PARTNERS GP, L.L.C.	3,580	400,000	0.01%
Ensign Peak Advisors, Inc	2,871	320,874	0.01%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	2,602	290,806	0.0%
Casdin Capital, LLC	2,526	282,312	0.19%